(Q39067346)

8 September 2017

Pathology of non-alcoholic fatty liver disease (English)

1 reference

non-alcoholic fatty liver

8 September 2017

0 references

1 reference

based on heuristic

inferred from title

metabolic dysfunction–associated steatotic liver disease

1 reference

Pierre Bedossa

1

0 references

publication date

1 January 2017

1 reference

8 September 2017

1 reference

8 September 2017

37 Suppl 1

1 reference

8 September 2017

85-89

1 reference

The global NAFLD epidemic

8 September 2017

1 reference

Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes.

21 January 2018

1 reference

The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association

21 January 2018

1 reference

Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists.

21 January 2018

1 reference

Effects of liver biopsy sample length and number of readings on sampling variability in nonalcoholic Fatty liver disease.

21 January 2018

1 reference

Utility and appropriateness of the fatty liver inhibition of progression (FLIP) algorithm and steatosis, activity, and fibrosis (SAF) score in the evaluation of biopsies of nonalcoholic fatty liver disease

21 January 2018

1 reference

Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease

21 January 2018

1 reference

Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease

21 January 2018

1 reference

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

21 January 2018

1 reference

Elafibranor, an Agonist of the Peroxisome Proliferator-Activated Receptor-α and -δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis Worsening

21 January 2018

1 reference

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: implications for prognosis and clinical management

21 January 2018

1 reference

Nonalcoholic fatty liver disease: pathology and pathogenesis

21 January 2018

1 reference

Histopathology of pediatric nonalcoholic fatty liver disease.

21 January 2018

1 reference

Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies

21 January 2018

1 reference

Long-term follow-up of patients with NAFLD and elevated liver enzymes

21 January 2018

1 reference

Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese

21 January 2018

1 reference

A clinical scoring system for predicting nonalcoholic steatohepatitis in morbidly obese patients

21 January 2018

1 reference

Endpoints and clinical trial design for nonalcoholic steatohepatitis

21 January 2018

1 reference

Design and validation of a histological scoring system for nonalcoholic fatty liver disease

21 January 2018

1 reference

Histopathological algorithm and scoring system for evaluation of liver lesions in morbidly obese patients.

21 January 2018

1 reference

Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-Clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network

21 January 2018

1 reference

Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

21 January 2018

1 reference

Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/LIV.13301

1 reference

8 September 2017

1 reference

PubMed ID

28052629